Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1Hematologic Diseases 1Gynecological Solid Tumors 1

Interventions

fludarabine 1Voriconazole 1Thalidomide 1Semen Analysis 1Remote Patient Monitoring 1Physical Examination 1Interviews as Topic 1Health Information Exchange 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Fluconazole 1Exercise 1Dexamethasone 1Cyclophosphamide 1Complementary Therapies 1Cell- and Tissue-Based Therapy 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Bismuth 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hematologic Diseases × Cell- and Tissue-Based Therapy × Clear all
NCT06849921 2025-02-27

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

Ruijin Hospital

Phase NA Active not recruiting
200 enrolled
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡